Showing results (731-740 of 835) with videos related to

Sort By:
Pageof 84
Journal of Virology|April 8, 2011
Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitorsRichard J P Brown, Paul J Peters, Catherine Caron, et al.
Pediatric Blood & Cancer|April 5, 2013
Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, C Patrick Reynolds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2000
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancerJ L Shenep, P M Flynn, D K Baker, et al.
Microbial Genomics|July 15, 2025
'Vivaldi': an amplicon-based whole-genome sequencing method for the four seasonal human coronaviruses, 229E, NL63, OC43 and HKU1, alongside SARS-CoV-2C Patrick McClure, Theocharis Tsoleridis, Jack D Hill, et al.
Pediatric Blood & Cancer|July 4, 2012
Initial testing of the MDM2 inhibitor RG7112 by the Pediatric Preclinical Testing ProgramHernan Carol, C Patrick Reynolds, Min H Kang, et al.
Journal of Medical Microbiology|August 17, 2019
Microbial epidemiology and carriage studies for the evaluation of vaccinesAbigail L Coughtrie, Johanna M Jefferies, David W Cleary, et al.
Pediatric Blood & Cancer|September 1, 2010
Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing ProgramE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium studyLars M Wagner, Judith G Villablanca, Clinton F Stewart, et al.
Chemmedchem|July 8, 2024
Coumarin-Based Aldo-Keto Reductase Family 1C (AKR1C) 2 and 3 InhibitorsSravan K Jonnalagadda, Ling Duan, Louise F Dow, et al.
Journal of Pharmaceutical Sciences|May 1, 2017
Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine CandidateWen-Hsiang Chen, Shivali M Chag, Mohan V Poongavanam, et al.
Pageof 84